Mor Oron Herman

Summary

Country: Israel

Publications

  1. ncbi request reprint The effects of allicin on weight in fructose-induced hyperinsulinemic, hyperlipidemic, hypertensive rats
    Amitai Elkayam
    Chorley Hypertension Research Institute, Chaim Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel
    Am J Hypertens 16:1053-6. 2003
  2. ncbi request reprint The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome
    Mor Oron-Herman
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Atherosclerosis 183:238-43. 2005
  3. ncbi request reprint Risk reduction therapy for syndrome X: comparison of several treatments
    Mor Oron-Herman
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Am J Hypertens 18:372-8. 2005
  4. ncbi request reprint Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model
    Yehonatan Sharabi
    Hypertension Unit, C Sheba Medical Center, Tel Hashomer, Israel
    Am J Hypertens 20:206-10. 2007
  5. doi request reprint Diagnostic targeting of colon cancer using a novel fluorescent somatostatin conjugate in a mouse xenograft model
    Genady Kostenich
    Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Israel
    Int J Cancer 122:2044-9. 2008
  6. doi request reprint Metabolic syndrome: comparison of the two commonly used animal models
    Mor Oron-Herman
    Hypertension Unit, C Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel
    Am J Hypertens 21:1018-22. 2008
  7. ncbi request reprint Hyperhomocysteinemia as a component of syndrome X
    Mor Oron-Herman
    Sackler Faculty of Medicine, Tel Aviv University, Israel
    Metabolism 52:1491-5. 2003
  8. ncbi request reprint Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction
    Zvi Ackerman
    Hebrew University Hadassah Medical Center, Jerusalem, Israel
    Hypertension 45:1012-8. 2005
  9. ncbi request reprint Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver
    Zvi Ackerman
    Department of Medicine, Hadassah Hebrew University Medical Center, Mount Scopus Campus, Jerusalem 91240, Israel
    Dig Dis Sci 53:777-84. 2008

Collaborators

Detail Information

Publications9

  1. ncbi request reprint The effects of allicin on weight in fructose-induced hyperinsulinemic, hyperlipidemic, hypertensive rats
    Amitai Elkayam
    Chorley Hypertension Research Institute, Chaim Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel
    Am J Hypertens 16:1053-6. 2003
    ..Thus, it was considered important to assess its effect on the weight of the animals...
  2. ncbi request reprint The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome
    Mor Oron-Herman
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Atherosclerosis 183:238-43. 2005
    ..We conclude that the combined molecule CPSSA integrates the anti-hypertensive, lipid-lowering, and homocysteine-reducing effects of both allicin and captopril, making it a potential cardiovascular protective agent...
  3. ncbi request reprint Risk reduction therapy for syndrome X: comparison of several treatments
    Mor Oron-Herman
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Am J Hypertens 18:372-8. 2005
    ..The present study compared the effects of antihypertensive, lipid-lowering, and insulin-sensitizing agents on the above-mentioned components of this metabolic syndrome...
  4. ncbi request reprint Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model
    Yehonatan Sharabi
    Hypertension Unit, C Sheba Medical Center, Tel Hashomer, Israel
    Am J Hypertens 20:206-10. 2007
    ..We studied the effect of the PPAR-gamma agonist rosiglitazone on adiponectin and the metabolic profile in the fructose-induced hypertensive, hyperinsulinemic, hypertriglyceridemic rat model...
  5. doi request reprint Diagnostic targeting of colon cancer using a novel fluorescent somatostatin conjugate in a mouse xenograft model
    Genady Kostenich
    Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Israel
    Int J Cancer 122:2044-9. 2008
    ..In conclusion, the SST conjugate significantly enhanced the detection of HT-29 colon tumors by fluorescence imaging because of a 5- to 8-fold increase in the contrast between malignant and normal tissues...
  6. doi request reprint Metabolic syndrome: comparison of the two commonly used animal models
    Mor Oron-Herman
    Hypertension Unit, C Sheba Medical Center, Tel Hashomer, Tel Aviv, Israel
    Am J Hypertens 21:1018-22. 2008
    ..The two most commonly studied animal models of the MS are the high-sucrose diet given to spontaneously hypertensive rats (SHRs) and high-fructose diet given to Sprague Dawley rats (SDRs). This study compares between these two models...
  7. ncbi request reprint Hyperhomocysteinemia as a component of syndrome X
    Mor Oron-Herman
    Sackler Faculty of Medicine, Tel Aviv University, Israel
    Metabolism 52:1491-5. 2003
    ..It is thus highly likely that hyperhomocysteinemia is an integral component of the human syndrome X as well, and thereby contributes to the overall high vascular risk associated with this condition...
  8. ncbi request reprint Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction
    Zvi Ackerman
    Hebrew University Hadassah Medical Center, Jerusalem, Israel
    Hypertension 45:1012-8. 2005
    ..Drugs administered to treat various aspects of the metabolic syndrome could have hepatic effects. An increase in HIC in rats with NAFLD could be associated with increased hepatic fibrosis...
  9. ncbi request reprint Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver
    Zvi Ackerman
    Department of Medicine, Hadassah Hebrew University Medical Center, Mount Scopus Campus, Jerusalem 91240, Israel
    Dig Dis Sci 53:777-84. 2008
    ..Drugs administered to treat hypertension and hypertriglyceridemia could lead to a variety of changes in the hepatic oxidative, anti-oxidative milieu...